Faculty profile

Carter Thorne

ResearcherUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Carter Thorne

Researcher

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
7 publications in the last five years, latest in 2026.
Principal investigator on 1 research grant (1 CIHR), most recently in 2022.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Comparative Effectiveness Research Implementation Science Interdisciplinary Model Of Care Learning Health System Musculoskeletal Health And Arthritis Quality Improvement Quality Of Care Rheumatic Diseases

Latest papers

Constructing the program theory: an implementation science approach to understanding a successful interdisciplinary team-based model of rheumatology care.
Implementation science communications · 2026
Distinct Systemic Sclerosis Phenotypes Related to Ethnicity: An Opportunity to Personalize Care?
Arthritis Care and Research · 2026
Improving outcomes of patients living with psoriatic arthritis: The Observational Best Practices Research Initiative (OBRI-PsA) registry: Rationale, Methodology and Preliminary Data of 18 Months Follow-up
PLoS ONE · 2026

All 26 publications

Latest funding

The Ontario Rheumatology Learning Health System for Transforming Integrated Care for Patients with Rheumatic and Musculoskeletal Disorders
CIHR · 2022 · Principal investigator
$1,981,515
A pragmatic registry-based randomized trial of drug tapering in rheumatoid arthritis
CIHR · 2017 · Co-investigator
$638,776
Leveraging Electronic Medical Records and Health Administrative Data to Evaluate Patient Care and Outcomes in Osteoarthritis
CIHR · 2016 · Co-investigator
$100,000

All 7 grants and awards

26 publications.

Constructing the program theory: an implementation science approach to understanding a successful interdisciplinary team-based model of rheumatology care.

King LK, To D, Ladak Z, Oliva L, Barnes C, Hofstetter C, Tin D, Thorne C, Ivers N, Widdifield J, Laur C, Canadian Rheumatology Implementation Science Team (CAN-RIST)

Implementation science communications2026

DOI: 10.1186/s43058-026-00870-w PMID: 41645304

Distinct Systemic Sclerosis Phenotypes Related to Ethnicity: An Opportunity to Personalize Care?

Goulet D, Guertin C, Larché M, Ferdinand I, Hudson M, Choi MY, Osman M, Pope J, Thorne C, Baron M

Arthritis Care and Research20261 citations

DOI: 10.1002/acr.80098

Improving outcomes of patients living with psoriatic arthritis: The Observational Best Practices Research Initiative (OBRI-PsA) registry: Rationale, Methodology and Preliminary Data of 18 Months Follow-up

Attar RZ, Movahedi M, Cesta A, Li X, Sabido-Sauri R, Tsechelidis OB, Lau A, Chow A, Thorne C, Haaland D

PLoS ONE2026

DOI: 10.1371/journal.pone.0352264

Beyond Cost: Observations on Clinical and Patient Benefits of Biosimilars in Real-World Settings.

Kvien TK, Betteridge N, Brückmann I, Bodenmüller W, Bryn G, Danese S, Gonçalves J, Maravic Z, Thorne C, Wingate L, Cornes P

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2025

DOI: 10.1007/s40259-025-00727-z PMID: 40473917

Residual Disease Activity and Burden of Disease in Canadian Patients With Axial Spondyloarthritis: Results From a Multiregistry Analysis (UNISON-Axial SpA).

Choquette D, Gladman DD, Inman RD, Rahman P, Laliberté MC, Fournier PA, Girard T, Wichuk S, Coupal L, Chandran V, Rohekar S, Boyd T, Zummer M, Richard N, Thorne C, Mosher D, Ziouzina O, Tsoukas A, Starr M, Chan J, Aydin SZ, Maksymowych WP

The Journal of rheumatology2025

DOI: 10.3899/jrheum.2024-1303 PMID: 40592555

Severe fatigue is associated with diminished lung function and elevated Galectin-9 levels in early systemic sclerosis

van Eeden C, Rezaeifar M, Elezzabi M, Redmond D, Gniadecki R, Abey A, Reynolds E, Sholter D, Shahbaz S, Elahi S

Frontiers in Immunology20251 citations

DOI: 10.3389/fimmu.2025.1655414

Predictors of depression trajectories during the COVID-19 pandemic in adults with rheumatoid arthritis: results from the Canadian Early Arthritis Cohort

Bartlett SJ, Schieir O, Valois M-F, Boire G, Tin D, Pope JE, Hitchon CA, Hazlewood G, Thorne C, Bessette L

Rheumatology Advances in Practice2025

DOI: 10.1093/rap/rkaf120

Safety and therapeutic value of radiosynoviorthesis with yttrium-90: a Canadian single-centre experience.

Zeiadin N, Rampakakis E, Turcotte E, Senta H, Sampalis JS, Thorne C

Rheumatology (Oxford, England)2021Senior author

DOI: 10.1093/rheumatology/keaa637 PMID: 33221911

Long-term safety and efficacy of sirukumab for patients with rheumatoid arthritis who previously received sirukumab in randomised controlled trials (SIRROUND-LTE).

Aletaha D, Bingham CO, Karpouzas GA, Takeuchi T, Thorne C, Bili A, Agarwal P, Hsu B, Rao R, Brown K, Tanaka Y

RMD open2021

DOI: 10.1136/rmdopen-2020-001465 PMID: 33526709

Evaluation of Rheumatology Workforce Supply Changes in Ontario, Canada, from 2000 to 2030

Widdifield J, Bernatsky S, Pope JE, Kuriya B, Barber CEH, Eder L, Ahluwalia V, Ling V, Gozdyra P, Hofstetter C

Healthcare Policy202134 citationsSenior authorOpen Access

DOI: 10.12927/hcpol.2021.26428 PMID: W3135517093

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2022

Subject: Prospective PhD student: Comparative Effectiveness Research Dear Professor Thorne, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Constructing the program theory: an implementation science approach to understanding a successful interdisciplinary team-based model of rheumatology care." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "The Ontario Rheumatology Learning Health System for Transforming Integrated Care for Patients with Rheumatic and Musculoskeletal Disorders" (2022), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Carter Thorne

Research

Latest papers

Latest funding

Constructing the program theory: an implementation science approach to understanding a successful interdisciplinary team-based model of rheumatology care.

Distinct Systemic Sclerosis Phenotypes Related to Ethnicity: An Opportunity to Personalize Care?

Improving outcomes of patients living with psoriatic arthritis: The Observational Best Practices Research Initiative (OBRI-PsA) registry: Rationale, Methodology and Preliminary Data of 18 Months Follow-up

Beyond Cost: Observations on Clinical and Patient Benefits of Biosimilars in Real-World Settings.

Residual Disease Activity and Burden of Disease in Canadian Patients With Axial Spondyloarthritis: Results From a Multiregistry Analysis (UNISON-Axial SpA).

Severe fatigue is associated with diminished lung function and elevated Galectin-9 levels in early systemic sclerosis

Predictors of depression trajectories during the COVID-19 pandemic in adults with rheumatoid arthritis: results from the Canadian Early Arthritis Cohort

Safety and therapeutic value of radiosynoviorthesis with yttrium-90: a Canadian single-centre experience.

Long-term safety and efficacy of sirukumab for patients with rheumatoid arthritis who previously received sirukumab in randomised controlled trials (SIRROUND-LTE).

Evaluation of Rheumatology Workforce Supply Changes in Ontario, Canada, from 2000 to 2030

The Ontario Rheumatology Learning Health System for Transforming Integrated Care for Patients with Rheumatic and Musculoskeletal Disorders

A pragmatic registry-based randomized trial of drug tapering in rheumatoid arthritis

Leveraging Electronic Medical Records and Health Administrative Data to Evaluate Patient Care and Outcomes in Osteoarthritis

Leveraging Electronic Medical Records and Health Administrative Data to Evaluate Patient Care and Outcomes in Rheumatic Diseases

Interdisciplinary Dissemination and Local Adaptation Workshop for Canadian Recommendations for the Pharmacologic Management of Rheumatoid Arthritis

Creating an information system from a Primary Care Electronic Medical Record Administrative data Linked Database to improve Rheumatoid Arthritis Surveillance and Quality of Care

Empowering Patients as Active Partners in Their Care: Lupus Interactive Navigator (LIN)

Frequent collaborators

Claire Bombardier

Dianne Mosher

Sasha Bernatsky

Vivian Bykerk

Jessica Widdifield

Proton Rahman

Vinod Chandran

Proton Rahman

Sasha Bernatsky

Sabrina Hoa

Derek Allan Haaland

Murray Baron

Janet Pope

Lihi Eder

J Michael Paterson

Nigil Haroon

Margaret Larche

Sabrina Hoa

Andrew Chow

Shima Shahbaz

Mohammad Movahedi

Melanie Poulin-Costello

Robert Gniadecki

Arthur Lau

Marie Hudson